{"id":"W2600488379","doi":"10.1200/jco.2012.30.15_suppl.6596","title":"Omacetaxine mepesuccinate in chronic-phase chronic myeloid leukemia (CML) in patients resistant, intolerant, or both to two or more tyrosine-kinase inhibitors (TKIs).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nilotinib; Dasatinib; Internal medicine; Adverse effect; Imatinib; Gastroenterology; Myeloid leukemia; Imatinib mesylate; Bosutinib; Tyrosine kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007003456,0.0002925626,0.0004129727,0.0002372377,0.0003032361,0.0002952861,0.0001809649,0.0004254441,0.0006429897],"category_scores_gemma":[0.0005584674,0.0001373861,0.0003085071,0.0003101539,0.0002493675,0.0003043036,0.0002526647,0.0004585091,0.0001364367],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003265223,"about_ca_system_score_gemma":0.0004862499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006668828,"about_ca_topic_score_gemma":0.001598195,"domain_scores_codex":[0.9997945,0.00007156071,0.00002904804,0.00003748203,0.00002357179,0.00004379231],"domain_scores_gemma":[0.9996704,0.00006888977,0.0001021483,0.00001147844,0.00001449987,0.0001325602],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.08161068,0.002844324,0.6669031,0.0008695637,0.0003720894,0.004958265,0.0006813447,0.001073996,0.06143621,0.0002362859,0.002969147,0.176045],"study_design_scores_gemma":[0.008446774,0.1018335,0.8622372,0.0001172967,0.0004143186,0.009044119,0.0003622871,0.001252558,0.006648161,0.0001695854,0.009446802,0.00002737113],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963839,0.002698381,0.00007122381,0.0001748338,0.00001161035,0.00007857981,0.000111131,0.000004631876,0.0004657812],"genre_scores_gemma":[0.9980319,0.001097838,0.0001993707,0.0001470693,0.00004024023,0.00004582199,0.0002648237,0.000001271039,0.0001716526],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007003456,"threshold_uncertainty_score":0.003703773,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07203863384198393,"score_gpt":0.4499658444050667,"score_spread":0.3779272105630828,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}